600998.SS SHH
Jointown Pharmaceutical Group Co., Ltd.
1W: +3.7%
1M: +4.3%
3M: +4.1%
YTD: -3.4%
1Y: -5.6%
3Y: +1.8%
5Y: +3.9%
¥5.05 ($0.75)
+0.09 (+1.81%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$102.4B
+10.4% ▲
5Y CAGR: +7.6%
Total Liabilities
$68.8B
+8.7% ▲
5Y CAGR: +6.9%
Shareholders Equity
$27.2B
+13.6% ▲
5Y CAGR: +7.8%
Cash & Investments
$18.4B
+7.8% ▲
5Y CAGR: +8.6%
Total Debt
$11.7B
-7.7% ▼
5Y CAGR: -4.3%
Net Debt
-$5.7B
-32.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $14.8B | $14.7B | $17.2B | $16.9B | $17.4B |
| Short-Term Investments | $15M | $3.6B | $320M | $90M | $972M |
| Cash & ST Investments | $14.8B | $18.3B | $17.5B | $17.0B | $18.4B |
| Net Receivables | $32.5B | $32.7B | $30.5B | $34.1B | $37.4B |
| Inventory | $14.8B | $15.5B | $17.2B | $20.1B | $22.9B |
| Other Current Assets | $9.2B | $8.8B | $10.3B | $271M | $216M |
| Total Current Assets | $66.2B | $71.2B | $75.7B | $75.6B | $84.2B |
| Property, Plant & Equip. | $7.4B | $8.5B | $8.6B | $9.0B | $9.0B |
| Goodwill & Intangibles | $2.8B | $2.9B | $2.8B | $2.8B | $3.0B |
| Long-Term Investments | $3.7B | -$1.2B | $3.0B | $3.6B | $3.2B |
| Other Non-Current Assets | $482M | $4.3B | $1.7B | $1.4B | $2.4B |
| Total Non-Current Assets | $14.7B | $14.8B | $16.6B | $17.2B | $18.2B |
| Total Assets | $80.8B | $85.9B | $92.3B | $92.8B | $102.4B |
| — Liabilities — | |||||
| Accounts Payable | $26.7B | $34.2B | $33.8B | $40.1B | $46.5B |
| Short-Term Debt | $14.5B | $12.6B | $12.0B | $10.1B | $9.9B |
| Deferred Revenue | $5.6B | $6.2B | $2.5B | $0 | $0 |
| Other Current Liabilities | -$333M | $2.5B | $5.1B | $4.1B | $3.6B |
| Total Current Liabilities | $51.3B | $55.4B | $59.7B | $60.1B | $66.4B |
| Long-Term Debt | $3.2B | $2.4B | $3.0B | $2.3B | $1.0B |
| Other Non-Current Liab. | $93M | $77M | $114M | $361M | $103M |
| Total Non-Current Liabilities | $3.9B | $3.5B | $3.9B | $3.2B | $2.4B |
| Total Liabilities | $55.2B | $58.9B | $63.6B | $63.3B | $68.8B |
| — Equity — | |||||
| Common Stock | $1.9B | $1.9B | $1.9B | $3.9B | $5.0B |
| Retained Earnings | $9.3B | $10.6B | $11.9B | $12.7B | $14.1B |
| Accumulated OCI | $761M | $1.2B | $1.1B | $0 | $0 |
| Total Stockholders Equity | $21.8B | $23.4B | $24.6B | $24.0B | $27.2B |
| Total Liabilities & Equity | $80.8B | $85.9B | $92.3B | $92.8B | $102.4B |
| — Key Metrics — | |||||
| Total Debt | $17.7B | $17.0B | $15.2B | $12.6B | $11.7B |
| Net Debt | $2.9B | $2.3B | -$2.0B | -$4.3B | -$5.7B |
| Total Investments | $3.7B | $2.4B | $3.4B | $3.6B | $4.2B |